Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04344197
Recruitment Status : Enrolling by invitation
First Posted : April 14, 2020
Last Update Posted : April 14, 2020
Sponsor:
Information provided by (Responsible Party):
Vittoria Bellato, University of Rome Tor Vergata

Brief Summary:
a brief questionnaire to get a clearer picture of the situation regarding surgical patients with special emphasis on asymptomatic Covid-19 patients.

Condition or disease Intervention/treatment
Surgery COVID Asymptomatic Patient Covid-19 Preventive Measures Other: global survey

Detailed Description:

With new evidence on the role of asymptomatic patients in spreading the disease during the Covid-19 pandemic, symptom driven guidelines for testing, hospital allocation and personal protective equipment (PPE) use do not seem appropriate to limit in-hospital transmission. At time when lockdowns are in place in most countries, hospitals can become the new source of infection.

Guidelines are very variable depending on local policies and availability of medical supplies, resulting in most hospitals taking different preventive measures.

Layout table for study information
Study Type : Observational
Actual Enrollment : 1200 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey
Actual Study Start Date : April 2, 2020
Actual Primary Completion Date : April 8, 2020
Estimated Study Completion Date : April 15, 2020

Intervention Details:
  • Other: global survey
    surgery questionnaire


Primary Outcome Measures :
  1. overview of surgical management on preventive measures of hospital infection spread during covid 19 [ Time Frame: 2/04/2020 to 15/04/2020 ]

Secondary Outcome Measures :
  1. testing policies and preventive measures for Covid-19, and their association with asymptomatic cases. [ Time Frame: 02/04/2020 to 15/04/2020 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
surgeon
Criteria

Inclusion Criteria:

general surgeon

Exclusion Criteria:

other speciality


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04344197


Locations
Layout table for location information
Italy
Tor Vergata Hospital
Rome, Italy, 00133
Sponsors and Collaborators
University of Rome Tor Vergata
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Vittoria Bellato, M.D., University of Rome Tor Vergata
ClinicalTrials.gov Identifier: NCT04344197    
Other Study ID Numbers: s-covid survey
First Posted: April 14, 2020    Key Record Dates
Last Update Posted: April 14, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No